Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.
about
Lipid Nanoparticles for Ocular Gene DeliveryChitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems.Solid lipid nanoparticles for ocular drug delivery.Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation.Toxicity of nanomaterials to the eye.A novel ion-exchange carrier based upon liposome-encapsulated montmorillonite for ophthalmic delivery of betaxolol hydrochloride.Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.In vitro cell culture models to study the corneal drug absorption.Nanoparticles in the ocular drug delivery.Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals.Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine.Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.Application of lipid nanoparticles to ocular drug delivery.Nanoparticles for drug delivery to the anterior segment of the eye.A comparative evaluation of coenzyme Q10-loaded liposomes and solid lipid nanoparticles as dermal antioxidant carriers.Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent.Low molecular weight chitosan-coated liposomes for ocular drug delivery: in vitro and in vivo studies.Encapsulation of ritonavir in solid lipid nanoparticles: in-vitro anti-HIV-1 activity using lentiviral particles.Novel nanostructured lipid carrier-based inserts for controlled ocular drug delivery: evaluation of corneal bioavailability and treatment efficacy in bacterial keratitis.A new approach to the treatment of recurrent aphthous stomatitis with bioadhesive gels containing cyclosporine A solid lipid nanoparticles: in vivo/in vitro examinations.Characterization and evaluation of 5-fluorouracil-loaded solid lipid nanoparticles prepared via a temperature-modulated solidification technique.Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applicationsEffect of different lipids and surfactants on formulation of solid lipid nanoparticles incorporating tamoxifen citrate.Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion methodRelevance of Lipid-Based Products in the Management of Dry Eye Disease.Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system.Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study.Nanomedicine for immunosuppressive therapy: achievements in pre-clinical and clinical research.Recent advances in topical nano drug-delivery systems for the anterior ocular segment.Modification of solid lipid nanoparticles loaded with nebivolol hydrochloride for improvement of oral bioavailability in treatment of hypertension: polyethylene glycol versus chitosan oligosaccharide lactate.Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.Nanomicelle formulation for topical delivery of cyclosporine A into the cornea: in vitro mechanism and in vivo permeation evaluation.Intestinal Lymphatic Delivery of Praziquantel by Solid Lipid Nanoparticles: Formulation Design,In VitroandIn VivoStudiesA Comprehensive Review on Dry Eye Disease: Diagnosis, Medical Management, Recent Developments, and Future ChallengesCyclosporine A-Loaded Solid Lipid Nanoparticles: Ocular Tolerance andIn VivoDrug Release in Rabbit Eyes
P2860
Q26823895-AC5BB488-C2C8-4D9F-BDED-2EF36E0E4059Q33733579-998A58E8-153B-42AB-A5B1-F434E9E25882Q34116807-D1C989C5-4C0E-4C51-A498-4307373CF18BQ36697414-45704DAA-2D04-464C-B459-6D4D40454E7AQ37676123-AAD59FAA-8235-4B1E-B587-F047E521A99AQ37684644-344F15C6-2AF4-4448-A52B-D6E9B2B18095Q37769529-CFFE9BDD-3CC2-4927-851E-CBA9826C62A4Q37850457-100EF154-DDFE-4560-9737-42215116E8EBQ38119238-BFD0D6A9-3C65-4910-87CC-44F3AFD6E84DQ38242752-34D1A3A5-3867-4831-82B4-672B4C426D45Q38558905-4BFE77B5-CDA1-4ABD-A43A-9E75A0B249ACQ38648168-756D04FB-36FC-446F-BEE6-BF1B63DAE956Q38862505-3B03D9D4-CB9C-491E-9E5A-8900F45DD12CQ39230212-57DDD42A-DBB2-4393-8725-A8A981E20D10Q39261715-A933425C-8323-49FD-9880-A33D61F0F013Q39285717-C10E50D6-C1D8-49EA-BC5C-098766AD59E2Q39445881-D2E3CD76-B8F8-4DBD-B3ED-094961836B43Q40215796-25494A33-5CD4-4BF4-9D93-755552FF3381Q41116182-8897F611-F4F2-4221-816F-69667C61E984Q41159576-9267F924-A830-4FB8-B6F5-D0917FDEF859Q41867368-CA4A1E2D-E000-4B39-94DC-4CD1C96869FFQ42111809-D71102EC-51A6-4766-9AE1-C88C2B9845E3Q42288616-14ADC450-F7FC-4089-ABDF-89067C0658E4Q42426554-C8F595D1-BC68-4213-BB90-E0B67B4B8438Q43119649-85945C90-73DE-4E34-82E2-F1AA2C4FE3B4Q43259069-75766F9A-BBFD-4011-A7FF-CCB5B0B4085CQ43811991-B9B1B185-01E3-44AD-80F6-BDA1BAC09B12Q47576736-EB5BCE78-EF38-41BC-9CAD-CD0890F5533CQ47771876-96947C31-B352-4642-978B-B7898D7A8D27Q50082031-02C4A208-2D8C-4A97-94B7-93A97E055092Q50927252-0633B1DA-1F0A-41B3-A903-339EC173B0E8Q51286120-DB1F997C-F694-445F-8800-27C6BE4F7A5AQ54839313-46A10554-6E8F-4C51-833C-D69F12E272B1Q59060853-DE27440D-A4B9-4766-BE2B-3F4526610757Q59104204-8A8BD7DB-7444-4A4C-BE48-63546FD4DECFQ59155923-CC9E593C-DF03-4D25-A668-76D77AF0CB00
P2860
Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.
@ast
Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.
@en
type
label
Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.
@ast
Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.
@en
prefLabel
Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.
@ast
Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.
@en
P2093
P1476
Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity
@en
P2093
Carla Caramella
Evren H Gokce
Franca Ferrari
Silvia Rossi
Tamer Güneri
P356
10.1016/J.IJPHARM.2008.07.028
P407
P577
2008-08-03T00:00:00Z